Her Itchy Legs And Fatigue Were Warning Signs Of Rare Cancer, But Doctors ‘Dismissed' Them
A CT scan revealed that Emma Simms has an 8 cm tumour in her chest, some of which had spread to her right lung.
A woman in the UK was struggling with exhaustion, itchy legs and weight loss for years. She was diagnosed with cancer after her symptoms were initially 'dismissed" by the doctors. Emma Simms, a 32-year-old from Stratford-upon-Avon, 'knew for years" that something was wrong, but she was repeatedly assured by doctors that she was fine.
According to Bristol Live, Emma had been feeling fatigued and dealing with persistent itching on her legs, but her condition didn't improve. 'I was turned away three times by my GP and even ended up in A&E," Emma said.
Despite undergoing blood tests and being reassured that she didn't have lymphoma, her symptoms continued to worsen. One doctor even assured her, 'You don't have leukemia, you don't have lymphoma. Everything's come back great."
It wasn't until December last year that Emma was referred to the haematology department at Churchill Hospital in Oxford. There, a CT scan revealed the shocking truth: an 8 cm tumour in her chest, some of which had spread to her right lung. She was diagnosed with Hodgkin's lymphoma, a rare blood cancer.
'I was told over the phone a couple of weeks before the biopsy confirmed it, so I had a bit of time to get my head around it," Emma said. Still, seeing the scan and being faced with the reality of her condition left her shaken. 'How did this happen? How was it missed for so long?" she wondered.
Before her diagnosis, Emma had been working for a tech marketing platform based in New Zealand. Exhausted all the time, she didn't have many hobbies. 'I didn't realise it was the cancer making me feel this way. Now that I know, I'm excited to change that."
Her treatment began with an aggressive chemotherapy regimen. 'It was terrifying, but given how big the tumour was, I wanted to go in hard. I've just finished my second cycle, and if things look promising on my next scan, I'll be able to switch to a different chemo regimen called ABVD," Emma said.
But the treatment came with challenges as Emma has been dealing with side effects like severe bone pain from injections, vomiting and weight gain due to steroids. Still, she remained resilient and even embraced the loss of her hair. 'I thought I'd wear my wig constantly, but I mostly just go bald now or wear a hat," she said.
Emma has found a supportive community on TikTok where she shares her journey openly. 'Talking about my journey has connected me with so many amazing people. It really helps me feel less alone," she said. Her partner, Calvin, has been her biggest support. 'He's been incredible. I don't know how I'd manage without him."
According to the Mayo Clinic, Hodgkin lymphoma is a cancer that affects the lymphatic system, which is part of the body's immune system that helps fight infections. It starts when healthy cells in the lymphatic system grow uncontrollably.
First Published:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
United News of India
an hour ago
- United News of India
Kerala CM leaves for Mayo Clinic in US for treatment
Thiruvananthapuram, July 5 (UNI) Kerala Chief Minister Pinarayi Vijayan, along with his wife, flew to the United States today for specialized medical treatment. The Chief Minister, whose trip is scheduled for ten days, departed from Thiruvananthapuram Airport in the early hours via Dubai. He is visiting the renowned Mayo Clinic in Rochester, Minnesota, for follow-up consultation and further treatment, having previously sought care at the same facility. During his foreign visits, the Chief Minister typically does not delegate responsibilities. He usually attends cabinet meetings online and oversees urgent official matters remotely. His wife, T. Kamala, and personal staff member V.M. Suneesh accompanied him on the trip. Although the Chief Minister had initially planned to travel to the US before the Nilambur by-election, the visit was postponed due to election-related commitments. The journey was finalized as the medical evaluations and treatment could no longer be delayed. The Chief Minister's visit comes at a time when the state's healthcare system is facing widespread criticism and public outrage. Amidst this backdrop, controversy continues over a recent incident in which a woman died following the collapse of a building at Kottayam Medical College. Critics have pointed out that the Chief Minister did not meet the family of the deceased, Bindu. In contrast, the Oommen Chandy Foundation (named after the late Congress Chief Minister) has extended Rs 5 lakh to help the family complete the construction of their house. The Chief Minister's departure follows a viral Facebook post by Dr. Harris Chiraykkal, Head of the Urology Department at Thiruvananthapuram Medical College, which highlighted systemic issues in the hospital and triggered public concern over the state's healthcare infrastructure. Meanwhile, the tragic death at Kottayam Medical College has intensified the political storm, prompting the Opposition to organize statewide protests demanding the resignation of Health Minister Veena George. It is amidst this politically and socially charged atmosphere that the Chief Minister has left for the United States. He also underwent treatment at the Mayo Clinic in 2018, 2022 and 2023. UNI DS RKM
Time of India
5 hours ago
- Time of India
Gujarat hospitals see worrying resistance to powerful antibiotics
SLUG: STATE's AMR PROFILE Ahmedabad: A recent govt study has revealed a worrying trend in Gujarat's hospitals — some of the most powerful antibiotics are no longer effective against common bacterial infections. The report found that more than 40% of E. coli and Klebsiella bacteria — two major antimicrobial-resistant (AMR) pathogens often responsible for serious infections — are now resistant to carbapenems, a high-end antibiotic typically used when all others fail. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad This is one of the key findings of the surveillance report by the Gujarat State Antimicrobial Resistance Surveillance Network (GUJSAR), released on Wednesday. The report analysed 14,685 AMR isolates collected between July 1 and December 31, 2024, from 22 network laboratories, including microbiology labs of six govt medical colleges, 13 GMERS medical colleges, and three municipal corporation-run medical colleges. "While other drugs are still available — including colistin, the last resort for very severe bacterial infections — resistance to carbapenems signals that we are rapidly running out of feasible antibiotic options for serious infections. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 今すぐ、2025年最高のRPGゲームを制覇しよう！ BuzzDaily Winners ゲームをプレイ Undo Switching to a higher class of antibiotics also brings short-term and long-term side effects," said a senior city-based microbiologist. A senior state health department official told TOI that Gujarat is among the few Indian states with a dedicated AMR surveillance network. "All steps — from identifying antimicrobial resistance to specific antibiotics to reporting isolates — are standardized," the official said. T he report focuses on priority pathogens, identified by the World Health Organization (WHO) as posing the highest threat to human health due to their resistance to existing antibiotics. The findings show that the majority of AMR isolates were from urine samples (42%), followed by pus aspirates (31%). About 62% of the isolates came from hospitalized patients, and 16% from patients in intensive care units (ICUs). Sources said that AMR organisms have been rising steadily — a trend also highlighted in Indian Council of Medical Research (ICMR) reports. "In recent years, gram-negative bacteria have shown increased resistance to several commonly used antibiotics. Some bacteria isolated from blood cultures also showed resistance, suggesting that if the correct antibiotics are not administered in time, it can lead to septicaemia — a potentially life-threatening bloodstream infection," said a microbiologist.
Time of India
7 hours ago
- Time of India
Bhandara gets 1st cancer screening bus, Maha roll out soon
1 2 Nagpur: In a significant push towards early cancer detection in rural and remote areas, Maharashtra's Public Health Department began deploying mobile cancer screening vans across the state. Bhandara district inaugurated its first such facility — a 'Pink Bus' fitted with a mobile cancer screening unit — which will tour villages and towns to screen citizens for various cancers. The initiative was formally launched at the District Hospital in Bhandara. The mobile unit aims to provide timely diagnosis and treatment access to people living in far-flung regions, potentially saving countless lives through early intervention. At the event, citizens were urged not to delay screenings and to take proactive steps for their health. The inauguration ceremony was attended by Bhandara Lok Sabha MP Dr Prashant Padole, district collector Sanjay Kolte, Zilla Parishad health committee chairperson Anandji Malewar, civil surgeon Dr Deepchand Soyyam, district health officer Dr Milind Somkuwar, as well as doctors, nurses, and hospital staff in large numbers. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Scientists: Tinnitus? When tinnitus won't go away, do this (Watch) Hearing Magazine Undo Speaking about the broader rollout in the state, minister of state for public health Meghna Sakore-Bordikar informed the legislative assembly that eight cancer detection vans have already been procured through a competitive bidding process on the govt e-Marketplace (GeM) portal. Each van comes equipped with 44 medical devices, along with customised interiors and necessary furnishings. "These mobile vans will enable timely diagnosis and immediate treatment for cancer patients, especially in underserved regions," Bordikar said. She further assured that tenders will soon be floated to procure similar cancer detection buses for all districts in Maharashtra. However, the procurement process has come under scrutiny, with some elected representatives raising queries about the tendering procedure. Bordikar clarified that a thorough investigation is underway by the Directorate of Health Services, and a report is expected before the conclusion of the ongoing assembly session. Health officials expressed confidence that the initiative will significantly enhance cancer care efficiency in districts like Bhandara and contribute to saving lives through prompt detection and intervention.
